PAPPA and hepatocellular carcinoma: Among the cabozantinib-induced secreted factors, PAPPA was previously shown to be a stroma-secreted factor that can activate NFκB signaling in hepatocellular carcinoma (HCC) cells, and advanced stage HCC has higher expression levels of PAPPA [21].